About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Noile-Immune Biotech Inc.(4893) Summary

4893
TSE Growth
Noile-Immune Biotech Inc.
156
JPY
-4
(-2.50%)
Dec 23, 3:30 pm JST
1.00
USD
Dec 23, 1:00 am EST
Result
PTS
outside of trading hours
158.3
Dec 23, 3:18 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.38
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
159 JPY 1.01 USD
Previous Close Dec 20
160 JPY 1.01 USD
High Dec 23, 1:53 pm
160 JPY 1.02 USD
Low Dec 23, 9:45 am
153 JPY 0.97 USD
Volume
461,300
Trading Value
0.07B JPY 0.42M USD
VWAP
155.73 JPY 0.99 USD
Minimum Trading Value
15,600 JPY 100 USD
Market Cap
6.76B JPY 0.04B USD
Number of Trades
277
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
1,133
1-Year High Jul 22, 2024
13,759
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 0 2,793,000
Dec 6, 2024 0 2,951,000
Nov 29, 2024 0 2,930,800
Nov 22, 2024 0 2,921,900
Nov 15, 2024 0 3,133,200
Company Profile
Noile-Immune Biotech Inc. engages in the development of novel immunotherapies utilizing CAR-T cells for cancer treatment.
Sector
Pharmaceuticals